Viridian Therapeutics, Inc.\DE VRDN
NASDAQ VRDN
$19.35 +0.36 (+1.92%)
As of: Oct 2, 2026 · 2:16 PM EDT

Viridian Therapeutics, Inc.\DE (VRDN) Interest Expenses (2013 - 2026)

Updated

Viridian Therapeutics, Inc.\DE (VRDN) reported Interest Expenses of $8.31 million for Q2 2026, compared with $514,000 a year earlier and up 139.9% from the prior quarter.

Analysis

Viridian Therapeutics, Inc.\DE (VRDN) Interest Expenses (2013 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Viridian Therapeutics, Inc.\DE's Interest Expenses came in at $15.61 million, up 639.9% year-over-year; for FY2025, it came in at $4.95 million, up 125.2% from FY2024.

  • Interest Expenses has increased for three consecutive years, with a five-year compound annual growth rate of 57.7% (FY2020 to FY2025).
  • By year, Interest Expenses came in at $2.2 million in FY2024 (+65.1%), $1.33 million in FY2023 (+173.9%), $486,000 in FY2022 and $3,000 in FY2021 (-99.4%).
  • The Q2 2026 figure ranks as the highest quarterly Interest Expenses in data going back to Q2 2013.
  • Year over year, Interest Expenses gained in four of the last seven quarters, with growth averaging 152.5%.
  • The high point for year-over-year Interest Expenses in five years was Q4 2025 (growth of 534.8%); the low point was Q4 2021 (a decline of 98.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.46 million (Q1 2026), $3.28 million (Q4 2025) and $560,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Viridian Therapeutics, Inc.\DE 2.33 Bn 2.33 Bn - 8.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.31 Mn
Mar 31, 2026 3.46 Mn
Dec 31, 2025 3.28 Mn
Sep 30, 2025 560,000.00
Jun 30, 2025 514,000.00
Mar 31, 2025 550,000.00
Dec 31, 2024 517,000.00
Sep 30, 2024 529,000.00
Jun 30, 2024 597,000.00
Mar 31, 2024 587,000.00
Dec 31, 2023 400,000.00
Sep 30, 2023 600,000.00
Jun 30, 2023 166,000.00
Mar 31, 2023 165,000.00
Dec 31, 2022 168,000.00
Sep 30, 2022 164,000.00
Jun 30, 2022 154,000.00
Dec 31, 2021 3,000.00
Dec 31, 2020 180,000.00
Sep 30, 2020 93,000.00
API Access

Viridian Therapeutics, Inc.\DE Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=VRDN&period=max&api_key=YOUR_API_KEY